Q1 2026 Holdings
Filed 2026-05-15 | 30 holdings | $2.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $575.2M | 22,970,388 | 24.4% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $437.0M | 7,880,094 | 18.5% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $322.6M | 1,706,469 | 13.7% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $238.3M | 6,000,000 | 10.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $155.7M | 4,288,120 | 6.6% |
| Aktis Oncology Inc(AKTS) | COM ADDED | 01021M104 | $86.3M | 4,824,469 | 3.7% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $85.2M | 6,728,116 | 3.6% |
| CG Oncology Inc(CGON) | COM | 156944100 | $74.6M | 1,102,000 | 3.2% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $66.1M | 1,389,276 | 2.8% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $53.6M | 2,171,938 | 2.3% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $50.0M | 1,667,119 | 2.1% |
| Xencor Inc(XNCR) | COM | 98401F105 | $26.3M | 2,183,000 | 1.1% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $25.6M | 1,271,342 | 1.1% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $25.3M | 2,823,126 | 1.1% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $23.2M | 777,000 | 1.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $19.0M | 1,904,762 | 0.8% |
| Centessa Pharmaceuticals PLC(CNTA)Call | SPONSORED ADS | 152309100 | $16.3M | 410,800 | 0.7% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $15.4M | 789,500 | 0.7% |
| Erasca Inc(ERAS) | COM | 29479A108 | $14.6M | 900,000 | 0.6% |
| Eikon Therapeutics Inc(EIKN) | COM ADDED | 282564103 | $7.8M | 732,606 | 0.3% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $7.7M | 1,000,000 | 0.3% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $7.0M | 1,179,715 | 0.3% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $6.9M | 625,000 | 0.3% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $4.4M | 13,368,855 | 0.2% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $3.3M | 100,000 | 0.1% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $3.2M | 947,049 | 0.1% |
| Ibio Inc(IBIO) | COM NEW | 451033708 | $3.0M | 1,583,000 | 0.1% |
| Helix Acquisition Corp III USD | CL A ORD SHS ADDED | G4444S107 | $2.0M | 200,000 | 0.1% |
| Atara Biotherapeutics Inc(ATRA) | COM NEW | 046513206 | $471.1K | 99,593 | 0.0% |
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $129.5K | 4,444 | 0.0% |